DAFTAR PUSTAKA

1. Adegbite AB, Khan MI, Paine KW, Tan LK. The recurrence of intracranial meningiomas
after surgical treatment. J Neurosurg 1983;58:5l-6.
2. Breiman RS, Beck JW, Korobkin M, Glenny R, Akwari OE, Heaston DK, Moore AV,
Ram PVC. Volume determinations using computed tomography. AJR 1982;138:329-33.
3. Carella RJ, Ransohoff J, Newall J. Role of radiation therapy in the management of
meningioma. Neurosurgery 1982;332-9.
4. Christensen D, Laursen H, Klinken L. Prediction of recurrence in meningiomas after
surgical treatment. Acta Neuropathol (Berl) 1983;6 I: 130-4.
5. Crompton MR, Gautier-Smith PC. The prediction of recurrence in meningiomas. J
Neurol Neurosurg Psychiatry 1970;33:80-7.
6. DietemannJL, Heldt N, BurquetJL, Medjek L, Maidrot D, Wackenheim A. CT findings in
malignant meningiomas. Neuroradiology 1982,23:207-9.
7. Fabiani A, Trebini F, Favero M, Peres B, Palmucci L. The significance of atypical
mitoses in malignant meningiomas. Acta Neuropathol (Bed) 1977;38:229-31.
8. Goellner JR, Laws ER, Soule EH, Okazaki H. Hemangiopericytoma of the meninges.
Mayo Clinic experience. Am J Clin Pathol 1978~70:375-80.
9. Inoue H, Tamamura M, Koizumi H, Nakamura M, Naganuma I-I, Ohye C. Clinical
pathology of malignant meningiomas. Acta Neurochir 1984;73:179-9l.
10. Jellinger K, Slowik F. Histological subtypes and prognostic problems in meningiomas. J
Neurol 1975;208:279-98.
11. Yamashima. lntracranial meningioma: radiology, surgery, radiotherapy and outcome in
21 patients. Surg Neurol 1985;23:227-36.
12. J~iskeliiinen J, Haltia M, Laasonen E, Wahlstr/3m T, Valtonen S. The growth rate of
intracranial meningioma and its relation to histology. An analysis of 43 patients. Surg
Neurol 1985;24:165-72.
13. Kepes JJ. Meningiomas. Biology, pathology, and differential diagnosis. In: Masson
monographs in diagnostic pathology. New York: Masson Publishing USA, 1982:112-23.
14. MacCarty CS, Taylor WF. lntracranial meningiomas: Experiences at the Mayo Clinic.
Neurol Med Chir (Tokyo) 1979;19:569-74.

29
15. J. L.Moretti, N. Hauet, M. Caglar, O. Rebillard, and Z. Burak, “To use MIBI or not to use
MIBI? That is the question when assessing tumour cells,” European Journal of
NuclearMedicine and Molecular Imaging, vol. 32, no. 7, pp. 836–842, 2005.
16. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma:
analysis of recurrence and progression following neurosurgical resection. J Neurosurg
1985;62:18-24.
17. New PFJ, Hesselink JR, O'Carroll CP, Kleinman GM. Malignant meningiomas: CT and
histological criteria, including a new CT sign. AJNR 1982;3:267-76.
18. Rubinstein LJ. Tumors of the central nervous system. In: Atlas of tumor pathology.
Washington, DC: Armed Forces Institute of Pathology, 1972.
19. Russell EJ, Ajax EG, Kricheff II, Budzilovich G. Atypical computed tomographic
features of intracranial meningiomas. Radiology 1980;135:673-82.
20. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol
Neurosurg Psychiatry 1957 ;201:22-39.
21. N. S. Petrovic, D. Grujicic, V. M. Artiko et al., “Investigation of blood perfusion and
metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile,”
Nuclear Medicine Communications, vol. 31, no. 11, pp. 962–973, 2010.
22. I. Ak, Z. Gulbas, F. Altinel, and E. Vardareli, “Tc-99m MIBI uptake and its relation to
the proliferative potential of brain tumors,” Clinical Nuclear Medicine, vol. 28, no. 1, pp.
29–33, 2003.
23. F. Cesani, R. Ernst, G. Storey, and J. Villanueva-Meyer, “Multicentric meningioma
evaluation with Tc-99m MIBI SPECT, CT, and MRI,” Clinical Nuclear Medicine, vol.
20, no.6, pp. 557–558, 1995.

29